
Alert: New Earnings Report (2/21/25)-Intra-Cellular Therapies Inc (NASDAQ: ITCI).
Intra-Cellular Therapies Inc (NASDAQ: ITCI) has reported E.P.S. of $-0.16 for its fourth fiscal quarter (ending December 31) versus $-0.30 for the same period a year ago — a decline of -47%. For the latest […]